BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17129225)

  • 1. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
    Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
    Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered mRNA expression of PAX5 is a common event in acute lymphoblastic leukaemia.
    Santoro A; Bica MG; Dagnino L; Agueli C; Salemi D; Cannella S; Veltroni M; Cetica V; Giarin E; Fabbiano F; Basso G; Arico M
    Br J Haematol; 2009 Sep; 146(6):686-9. PubMed ID: 19604238
    [No Abstract]   [Full Text] [Related]  

  • 4. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia.
    Best A; Matheson E; Minto L; Hall AG; Irving JA
    Leuk Res; 2010 Aug; 34(8):1098-102. PubMed ID: 20233627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
    Sullivan LM; Atkins KA; LeGallo RD
    Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
    Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
    Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
    Nebral K; König M; Harder L; Siebert R; Haas OA; Strehl S
    Br J Haematol; 2007 Oct; 139(2):269-74. PubMed ID: 17897302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of the transcription factor PAX5 in childhood acute leukemic cells].
    Zhang B; Tie LJ; Ye QD; Gu LJ; Tang JY; Yuan XL; Shen LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):6-10. PubMed ID: 16584581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
    Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
    Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities].
    Liu XM; Zhang L; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Chen XJ; Wang SC; Yang WY; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Apr; 18(4):287-91. PubMed ID: 27097569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.
    Dang J; Wei L; de Ridder J; Su X; Rust AG; Roberts KG; Payne-Turner D; Cheng J; Ma J; Qu C; Wu G; Song G; Huether RG; Schulman B; Janke L; Zhang J; Downing JR; van der Weyden L; Adams DJ; Mullighan CG
    Blood; 2015 Jun; 125(23):3609-17. PubMed ID: 25855603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
    Jumaa H; Bossaller L; Portugal K; Storch B; Lotz M; Flemming A; Schrappe M; Postila V; Riikonen P; Pelkonen J; Niemeyer CM; Reth M
    Nature; 2003 May; 423(6938):452-6. PubMed ID: 12761551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple isoforms of PAX5 are expressed in both lymphomas and normal B-cells.
    Arseneau JR; Laflamme M; Lewis SM; Maïcas E; Ouellette RJ
    Br J Haematol; 2009 Nov; 147(3):328-38. PubMed ID: 19725825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
    Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
    [No Abstract]   [Full Text] [Related]  

  • 20. One missense mutation in exon 2 of the PAX5 gene in Iran.
    Yazdanparast S; Khatami SR; Galehdari H; Jaseb K
    Genet Mol Res; 2015 Dec; 14(4):17768-75. PubMed ID: 26782422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.